Loading…

Gastric cancer survival in Sweden: lack of improvement in 19 years

A total of 34,549 patients constituting 87.0% of all patients with gastric cancer diagnosed in Sweden in 1960-1978 and reported to the National Cancer Registry were included in a complete follow-up over a period of 1-20 years. The poor outcome in this disease was again established in this unselected...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of surgery 1986-11, Vol.204 (5), p.546-551
Main Authors:	LUNDEGARDH, G, ADAMI, H.-O, MALKER, B
Format:	Article
Language:	English
Subjects:	Actuarial Analysis Adult Age Factors Aged Biological and medical sciences Female Gastroenterology. Liver. Pancreas. Abdomen Humans Male Medical sciences Middle Aged Registries Stomach Neoplasms - mortality Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Sweden Time Factors Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	551
container_issue	5
container_start_page	546
container_title	Annals of surgery
container_volume	204
creator	LUNDEGARDH, G ADAMI, H.-O MALKER, B
description	A total of 34,549 patients constituting 87.0% of all patients with gastric cancer diagnosed in Sweden in 1960-1978 and reported to the National Cancer Registry were included in a complete follow-up over a period of 1-20 years. The poor outcome in this disease was again established in this unselected material. Thus, the 5-year relative survival rate (with 95% confidence limits) was 12.7% (12.1-13.2%) among the men and 14.1% (13.4-14.9%) among the women, without any long-term difference between the sexes. The annual hazard rates in male and female patients were still 11.0% (8.3-13.7%) and 9.0% (7.1-10.9%), respectively, after 5 years and did not approach zero until 10 years after the diagnosis. Men older than 75 showed a slightly higher mortality during the first year, but there were seemingly no relationships of tumor-biological or clinical significance between age at diagnosis and long-term relative survival. The overall prognosis remained unchanged during the 19 years of the study, whereas the incidence was reduced by about 40% in the whole Swedish population.
doi_str_mv	10.1097/00000658-198611000-00007
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1251338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77086153</sourcerecordid><originalsourceid>FETCH-LOGICAL-p290t-141b01ffcd1c6a47dc6b7e0b47290fed7f65bcf7166fa1d2e65498719c7798553</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMotVZ_gpCDeFvNbDZfHgQtWoWCB_W8ZLOJRvejJt1K_70plqJzGeZ9hneGFyEM5AKIEpdkU5zJDJTkAGnINorYQ2NgeZKhIPtonCSaFYrmh-goxg9CoJBEjNCICi4KKcbodqbjMniDje6MDTgOYeVXusG-w8_ftrbdFW60-cS9w75dhH5lW9stNxgUXlsd4jE6cLqJ9mTbJ-j1_u5l-pDNn2aP05t5tsgVWWZQQEXAOVOD4boQteGVsKQqRMLO1sJxVhkngHOnoc4tZ4WSApQRQknG6ARd__ouhqq1tUlvBN2Ui-BbHdZlr335n3T-vXzrVyXkDCiVyeB8axD6r8HGZdn6aGzT6M72QyyFIClMRtPi6d9LuxPb1BI_23IdjW5cSNn5uFuThMmcKvoDn2V9LQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77086153</pqid></control><display><type>article</type><title>Gastric cancer survival in Sweden: lack of improvement in 19 years</title><source>PubMed Central</source><creator>LUNDEGARDH, G ; ADAMI, H.-O ; MALKER, B</creator><creatorcontrib>LUNDEGARDH, G ; ADAMI, H.-O ; MALKER, B</creatorcontrib><description>A total of 34,549 patients constituting 87.0% of all patients with gastric cancer diagnosed in Sweden in 1960-1978 and reported to the National Cancer Registry were included in a complete follow-up over a period of 1-20 years. The poor outcome in this disease was again established in this unselected material. Thus, the 5-year relative survival rate (with 95% confidence limits) was 12.7% (12.1-13.2%) among the men and 14.1% (13.4-14.9%) among the women, without any long-term difference between the sexes. The annual hazard rates in male and female patients were still 11.0% (8.3-13.7%) and 9.0% (7.1-10.9%), respectively, after 5 years and did not approach zero until 10 years after the diagnosis. Men older than 75 showed a slightly higher mortality during the first year, but there were seemingly no relationships of tumor-biological or clinical significance between age at diagnosis and long-term relative survival. The overall prognosis remained unchanged during the 19 years of the study, whereas the incidence was reduced by about 40% in the whole Swedish population.</description><identifier>ISSN: 0003-4932</identifier><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/00000658-198611000-00007</identifier><identifier>PMID: 3767487</identifier><identifier>CODEN: ANSUA5</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Actuarial Analysis ; Adult ; Age Factors ; Aged ; Biological and medical sciences ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Medical sciences ; Middle Aged ; Registries ; Stomach Neoplasms - mortality ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Sweden ; Time Factors ; Tumors</subject><ispartof>Annals of surgery, 1986-11, Vol.204 (5), p.546-551</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1251338/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1251338/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8058239$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3767487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LUNDEGARDH, G</creatorcontrib><creatorcontrib>ADAMI, H.-O</creatorcontrib><creatorcontrib>MALKER, B</creatorcontrib><title>Gastric cancer survival in Sweden: lack of improvement in 19 years</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>A total of 34,549 patients constituting 87.0% of all patients with gastric cancer diagnosed in Sweden in 1960-1978 and reported to the National Cancer Registry were included in a complete follow-up over a period of 1-20 years. The poor outcome in this disease was again established in this unselected material. Thus, the 5-year relative survival rate (with 95% confidence limits) was 12.7% (12.1-13.2%) among the men and 14.1% (13.4-14.9%) among the women, without any long-term difference between the sexes. The annual hazard rates in male and female patients were still 11.0% (8.3-13.7%) and 9.0% (7.1-10.9%), respectively, after 5 years and did not approach zero until 10 years after the diagnosis. Men older than 75 showed a slightly higher mortality during the first year, but there were seemingly no relationships of tumor-biological or clinical significance between age at diagnosis and long-term relative survival. The overall prognosis remained unchanged during the 19 years of the study, whereas the incidence was reduced by about 40% in the whole Swedish population.</description><subject>Actuarial Analysis</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Registries</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Sweden</subject><subject>Time Factors</subject><subject>Tumors</subject><issn>0003-4932</issn><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMotVZ_gpCDeFvNbDZfHgQtWoWCB_W8ZLOJRvejJt1K_70plqJzGeZ9hneGFyEM5AKIEpdkU5zJDJTkAGnINorYQ2NgeZKhIPtonCSaFYrmh-goxg9CoJBEjNCICi4KKcbodqbjMniDje6MDTgOYeVXusG-w8_ftrbdFW60-cS9w75dhH5lW9stNxgUXlsd4jE6cLqJ9mTbJ-j1_u5l-pDNn2aP05t5tsgVWWZQQEXAOVOD4boQteGVsKQqRMLO1sJxVhkngHOnoc4tZ4WSApQRQknG6ARd__ouhqq1tUlvBN2Ui-BbHdZlr335n3T-vXzrVyXkDCiVyeB8axD6r8HGZdn6aGzT6M72QyyFIClMRtPi6d9LuxPb1BI_23IdjW5cSNn5uFuThMmcKvoDn2V9LQ</recordid><startdate>19861101</startdate><enddate>19861101</enddate><creator>LUNDEGARDH, G</creator><creator>ADAMI, H.-O</creator><creator>MALKER, B</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19861101</creationdate><title>Gastric cancer survival in Sweden: lack of improvement in 19 years</title><author>LUNDEGARDH, G ; ADAMI, H.-O ; MALKER, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p290t-141b01ffcd1c6a47dc6b7e0b47290fed7f65bcf7166fa1d2e65498719c7798553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Actuarial Analysis</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Registries</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Sweden</topic><topic>Time Factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LUNDEGARDH, G</creatorcontrib><creatorcontrib>ADAMI, H.-O</creatorcontrib><creatorcontrib>MALKER, B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LUNDEGARDH, G</au><au>ADAMI, H.-O</au><au>MALKER, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastric cancer survival in Sweden: lack of improvement in 19 years</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>1986-11-01</date><risdate>1986</risdate><volume>204</volume><issue>5</issue><spage>546</spage><epage>551</epage><pages>546-551</pages><issn>0003-4932</issn><eissn>1528-1140</eissn><coden>ANSUA5</coden><abstract>A total of 34,549 patients constituting 87.0% of all patients with gastric cancer diagnosed in Sweden in 1960-1978 and reported to the National Cancer Registry were included in a complete follow-up over a period of 1-20 years. The poor outcome in this disease was again established in this unselected material. Thus, the 5-year relative survival rate (with 95% confidence limits) was 12.7% (12.1-13.2%) among the men and 14.1% (13.4-14.9%) among the women, without any long-term difference between the sexes. The annual hazard rates in male and female patients were still 11.0% (8.3-13.7%) and 9.0% (7.1-10.9%), respectively, after 5 years and did not approach zero until 10 years after the diagnosis. Men older than 75 showed a slightly higher mortality during the first year, but there were seemingly no relationships of tumor-biological or clinical significance between age at diagnosis and long-term relative survival. The overall prognosis remained unchanged during the 19 years of the study, whereas the incidence was reduced by about 40% in the whole Swedish population.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>3767487</pmid><doi>10.1097/00000658-198611000-00007</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0003-4932
ispartof	Annals of surgery, 1986-11, Vol.204 (5), p.546-551
issn	0003-4932 1528-1140
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1251338
source	PubMed Central
subjects	Actuarial Analysis Adult Age Factors Aged Biological and medical sciences Female Gastroenterology. Liver. Pancreas. Abdomen Humans Male Medical sciences Middle Aged Registries Stomach Neoplasms - mortality Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Sweden Time Factors Tumors
title	Gastric cancer survival in Sweden: lack of improvement in 19 years
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A59%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastric%20cancer%20survival%20in%20Sweden:%20lack%20of%20improvement%20in%2019%20years&rft.jtitle=Annals%20of%20surgery&rft.au=LUNDEGARDH,%20G&rft.date=1986-11-01&rft.volume=204&rft.issue=5&rft.spage=546&rft.epage=551&rft.pages=546-551&rft.issn=0003-4932&rft.eissn=1528-1140&rft.coden=ANSUA5&rft_id=info:doi/10.1097/00000658-198611000-00007&rft_dat=%3Cproquest_pubme%3E77086153%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p290t-141b01ffcd1c6a47dc6b7e0b47290fed7f65bcf7166fa1d2e65498719c7798553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77086153&rft_id=info:pmid/3767487&rfr_iscdi=true